Oxagen's Series C - II Round

Oxagen raised a round of funding on November 24, 2009. Investors include Wellington Partners.

Oxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.…

Articles about Oxagen's Series C - II Round: